ATS AH-Basic Series High-Pressure Homogenizer

Overview

The ATS AH-Basic Series High-Pressure Homogenizer is an engineered laboratory-scale system designed for reproducible, scalable cell disruption and nano-scale particle size reduction via hydrodynamic cavitation, impact, and shear forces. It operates on the principle of positive displacement pumping—where a precision-machined reciprocating plunger pressurizes liquid suspension into a dynamically adjustable homogenizing valve assembly. As the sample passes through a precisely defined orifice (typically 50–200 µm), it accelerates to velocities exceeding 1000 m/s before impinging upon an impact ring. This rapid pressure drop induces intense cavitation collapse, mechanical collision, and laminar shear—collectively enabling sub-100 nm particle size distribution in lipid-based formulations, protein suspensions, and colloidal dispersions. The system is purpose-built for early-stage pharmaceutical development, including liposome extrusion alternatives, nanoemulsion stabilization, and microbial cell lysis under controlled thermal conditions.

Key Features

• GMP-aligned mechanical architecture with fully drainable fluid path and zero-residue design—critical for high-value API intermediates and excipients.
• CE-certified safety compliance with integrated pressure relief valves, emergency stop circuitry, and real-time pressure monitoring.
• 2.2 kW industrial-grade motor coupled with variable-frequency drive (VFD) for precise flow rate control (0.5–10 L/h) across viscosity ranges up to 5000 cP.
• Homogenizing valve assembly constructed from ultra-high-density ceramic (optional) or hardened stainless steel—engineered for >5000 h service life under 1500 bar operation.
• Integrated water-cooled heat exchanger (non-contact type) maintains sample temperature within ±2 °C during extended operation—no dilution or solvent loss.
• Modular valve configuration supports single-stage primary homogenization or dual-stage processing for enhanced uniformity in multicomponent systems (e.g., PEGylated liposomes).
• All wetted surfaces fabricated from ASTM A276 316L stainless steel—passivated per ASTM A967 and compliant with USP extractables requirements.
• Tool-free disassembly of inlet/outlet manifolds and valve cartridges enables rapid cleaning validation and changeover between formulation batches.

Sample Compatibility & Compliance

The AH-Basic accommodates aqueous, organic, and biphasic suspensions—including lipid emulsions, bacterial lysates, plant extracts, and polymer nanodispersions—with inlet particle size tolerance up to 500 µm. Its validated operating envelope covers volumes from 50 mL (minimum batch) to 10 L/h continuous throughput. Regulatory alignment includes adherence to ISO 22000 hygiene principles for food-grade applications and compatibility with ICH Q5A viral clearance validation protocols in biopharmaceutical workflows. For GLP/GMP environments, the system supports audit-ready documentation packages including IQ/OQ/PQ templates, calibration logs, and traceable pressure transducer certification (TÜV-accredited).

Software & Data Management

While the base AH-Basic model features analog pressure gauges and manual valve adjustment, optional digital instrumentation integrates with ATS Homogenizer Control Suite v3.2—a Windows-based application supporting real-time logging of pressure, flow rate, temperature, and runtime. Data export complies with ASTM E2500-13 for raw data integrity and supports 21 CFR Part 11-compliant user authentication, electronic signatures, and immutable audit trails. Export formats include CSV, PDF reports, and XML metadata embedding for LIMS integration.

Applications

• Pharmaceutical R&D: Liposome encapsulation efficiency optimization, nanostructured lipid carriers (NLCs), and sterile filtration pre-treatment of parenteral emulsions.
• Biotechnology: Gram-negative and Gram-positive bacterial cell lysis, inclusion body solubilization, and membrane protein extraction without detergent overuse.
• Food Science: Cold-sterilized juice cloud stabilization, dairy protein micellization, and functional ingredient nanoencapsulation (e.g., curcumin, resveratrol).
• Materials Science: Graphene oxide dispersion, quantum dot colloid synthesis, and ceramic nanoparticle deagglomeration prior to spray drying.
• Academic Research: Scalable process mapping from lab (AH-Basic) to pilot (AH-Pro) to production (AH-Industrial) using identical valve geometry and pressure–energy correlation models.

FAQ

What is the minimum recommended sample volume for reliable pressure build-up?
50 mL is the validated lower limit; smaller volumes may result in unstable pressure regulation due to plunger dead-volume effects.
Can the AH-Basic process heat-sensitive biological samples without denaturation?
Yes—integrated cooling maintains sample temperature ≤35 °C during standard 1500 bar operation at 5 L/h flow rate.
Is third-party validation support available for regulatory submissions?
ATS provides protocol templates aligned with FDA guidance for equipment qualification and offers on-site IQ/OQ assistance by certified field engineers.
How frequently must the homogenizing valve be replaced under typical pharmaceutical use?
Ceramic valve lifetime exceeds 500 operational hours at 1200–1500 bar; stainless steel variants require replacement every 200–300 hours depending on abrasive load.
Does the system meet requirements for sterile processing in aseptic suites?
The AH-Basic is not autoclavable but supports SIP (steam-in-place) via external jacketed connections and qualifies for Grade C cleanroom installation when paired with HEPA-filtered air supply and isolator integration.